Evidence map›Paper›PMID 38617753›Full record

ArticleJournal of thoracic disease2024

Prognostic factors of recurrence and disease-free survival in radically resected pulmonary carcinoids: a real-world analysis.

Marc Spils, Thomas Klikovits, Dagmar Krenbek, Maximilian Johannes Hochmair, Igor Jankovic, Lisa Schulte, Tibor Krajc, Michal Benej, Vladyslav Getman, José Ruiz Navarrete and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Marc SpilsDepartment of Thoracic Surgery and Karl-Landsteiner-Institute, Clinic Floridsdorf, Vienna, Austria.
Thomas KlikovitsDepartment of Thoracic Surgery and Karl-Landsteiner-Institute, Clinic Floridsdorf, Vienna, Austria.
Dagmar KrenbekInstitute for Pathology, Clinic Floridsdorf, Vienna, Austria.
Maximilian Johannes HochmairDepartment of Respiratory and Critical Care Medicine, Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology, Clinic Floridsdorf, Vienna, Austria.
Igor JankovicDepartment of Thoracic Surgery and Karl-Landsteiner-Institute, Clinic Floridsdorf, Vienna, Austria.
Lisa SchulteDepartment of Thoracic Surgery and Karl-Landsteiner-Institute, Clinic Floridsdorf, Vienna, Austria.
Tibor KrajcDepartment of Thoracic Surgery and Karl-Landsteiner-Institute, Clinic Floridsdorf, Vienna, Austria.
Michal BenejDepartment of Thoracic Surgery and Karl-Landsteiner-Institute, Clinic Floridsdorf, Vienna, Austria.
Vladyslav GetmanDepartment of Thoracic Surgery and Karl-Landsteiner-Institute, Clinic Floridsdorf, Vienna, Austria.
José Ruiz NavarreteDepartment of Thoracic Surgery and Karl-Landsteiner-Institute, Clinic Floridsdorf, Vienna, Austria.
Ahmet AkanDepartment of Thoracic Surgery and Karl-Landsteiner-Institute, Clinic Floridsdorf, Vienna, Austria.
Michael R MuellerDepartment of Thoracic Surgery and Karl-Landsteiner-Institute, Clinic Floridsdorf, Vienna, Austria.
Clemens AignerDepartment of Thoracic Surgery, Vienna General Hospital, Vienna, Austria.
Stefan B WatzkaDepartment of Thoracic Surgery and Karl-Landsteiner-Institute, Clinic Floridsdorf, Vienna, Austria.
Vienna General Hospital · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pulmonary carcinoids (PCs) are rare neuroendocrine lung tumors which may recur, thus worsening their otherwise favorable overall prognosis. Aiming to identify patients at risk for recurrence, we examined parameters affecting disease-free survival (DFS). Methods: A retrospective single-center analysis of 82 consecutive patients undergoing curative intent resection for primary PC tumors between 2010 and 2019 was carried out. Kaplan-Meier method was utilized for survival analysis. Independent prognostic factors were determined using multivariable Cox and logistic regression. Results: During the observation period 82 patients, 48 females (58.5%) and 34 males (41.5%) were operated, representing 84 cases of PCs, 56 typical (TCs) (66.7%) and 28 atypical (ACs) (33.3%) carcinoids. Five-year overall survival was 87.5% and 84.7%, 5-year DFS 97.5% and 74.9% (P=0.012) for TCs and ACs, respectively. Recurrences occurred in one patient (1.8%) with TCs and five patients (17.9%) with ACs (P=0.014). Using multivariable Cox regression, tumor size (cm) remained as an independent prognostic factor for reduced DFS (P=0.018). In logistic regression, nodal involvement (P=0.043) and tumor size (cm) (P=0.023) were independently associated with higher risk of recurrence. Age, sex, smoking, location, and Ki-67 index were not independently associated with recurrence or DFS. Conclusions: Recurrence in PCs after complete resection is relatively rare. However, DFS is reduced in ACs compared to TCs. Tumor size (cm) and nodal involvement appear as the most important prognostic factors associated with recurrence in PCs, independent of histologic type.

Indexed as

disease-free-survival (DFS)Lung cancerprognosispulmonary carcinoid (PC)recurrence

Identifiers

PMID38617753
PMCPMC11009585
OpenAlexW4393050473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.